GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Buildings And Improvements

Takara Bio (TSE:4974) Buildings And Improvements : 円28,521 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Buildings And Improvements?

Takara Bio's quarterly buildings and improvements increased from Sep. 2023 (円29,193 Mil) to Dec. 2023 (円29,578 Mil) but then declined from Dec. 2023 (円29,578 Mil) to Mar. 2024 (円28,521 Mil).

Takara Bio's annual buildings and improvements increased from Mar. 2022 (円23,553 Mil) to Mar. 2023 (円28,098 Mil) and increased from Mar. 2023 (円28,098 Mil) to Mar. 2024 (円28,521 Mil).


Takara Bio Buildings And Improvements Historical Data

The historical data trend for Takara Bio's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Buildings And Improvements Chart

Takara Bio Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,478.00 15,670.00 23,553.00 28,098.00 28,521.00

Takara Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28,098.00 28,333.00 29,193.00 29,578.00 28,521.00

Takara Bio Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Takara Bio (TSE:4974) Business Description

Traded in Other Exchanges
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines